Subtyping Primary Aldosteronism With Para-chloro-2-[18F]Fluoroethyl-etomidate
Subtyping Primary Aldosteronism With Para-chloro-2-[18F]Fluoroethyl-etomidate
Recruiting · NCT06616142 · Registry updated 2025-01-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Subtyping Primary Aldosteronism With Para-chloro-2-[18F]Fluoroethyl-etomidate | adrenal gland disorder, adrenal gland hyperfunction, endocrine system disorder, hyperaldosteronism, primary aldosteronism | Recruiting | Phase 1 / Phase 2 | 2025-01-27 | NCT06616142 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University Medical Center Groningen | 213 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University Medical Center Groningen | Groningen | Netherlands | 16 |